Who we are: review.dental is published by the team behind Intake.Dental. We review the whole market, including our own product — and we tell you when a competitor is the better fit.

Diagnocat Review (2026): The Only Serious 3D/CBCT AI — Fresh Off Its US FDA Clearance

Facts & pricing verified July 3, 2026

Diagnocat attacks dental AI from the direction the US market leaders mostly haven’t: 3D. It analyzes full CBCT volumes — 65+ conditions per tooth — generates automated radiological reports, and auto-segments scans into exportable STL models you can take straight into surgical-guide planning. It’s operated in 50+ countries with its deepest roots in Europe, and it became a real US option only recently: K251072 (Sept 2025) and K252934 (Jan 2026), both verifiable in openFDA under its Miami-based US entity DGNCT, LLC.

What it actually does

2D analysis (pano, bitewing, periapical — reports in under a minute) plus the CBCT suite: full-volume AI reports in 4–6 minutes, automatic segmentation to STL, implant and ortho reports, and a 3D viewer with MPR tools. A 12-month, hundreds-of-cases independent review by the Institute of Digital Dentistry landed on a telling phrase: “it will consistently pick up findings… rarely misses” — consistency being exactly what you want from a second reader.

One nuance US buyers must understand: the international marketing is broader than the US clearance. Diagnocat’s own pages note that regulatory clearance varies by country and some features may not be available in all regions. Ask specifically which report types are FDA-cleared for US clinical use.

Pricing

Quote-only in the US. Internationally-circulated figures — €129/month for a 2D tier and €249/month for a 3D tier (5 CBCT reports/month, DICOM-to-STL, 100GB) — could not be confirmed on official pages as of July 2026, so treat them as directional. Structural facts confirmed from the vendor’s FAQ: subscription-only (no pay-per-report), CBCT reports are capped per tier, unused reports don’t roll over, and the auto-upload desktop app is a paid add-on. Euro-denominated billing adds currency wobble for US practices.

Strengths

  • The only comprehensive 2D+3D AI — if you place implants or read a lot of CBCT, nothing else on this site does what it does.
  • Automatic STL segmentation genuinely eliminates hours of manual work for guided surgery.
  • Fast, consistent screening validated by a rare truly independent long-term review.
  • Patients respond to the “neutral third-party” AI report — reviewers note improved case acceptance.

Weaknesses

  • Artifact-driven false findings (metal restorations especially); early versions misread amalgam pins as root canal fillings — since fixed, but indicative of black-box risk.
  • Specialty depth is thin: ceph tracings, endo, and implant reports described as basic; no virtual implant placement.
  • Cloud-batch workflow, not chairside-real-time; needs reliable internet.
  • Brand-new to the US market — thin domestic track record, support network, and integration story; report caps and no-rollover policy can pinch high-CBCT-volume months.

Verdict

For implant, oral surgery, and CBCT-heavy practices, Diagnocat is the only AI on this site solving your actual problem, and it’s worth a demo despite the US newness. For a general practice that mostly reads bitewings, the established 2D players (Pearl, Overjet, Denti.AI) are the more proven, better-supported path.

Sources: openFDA 510(k) records for DGNCT, Diagnocat US, FAQ, US launch announcement, Institute of Digital Dentistry 12-month review, The Molar Report.

Frequently asked questions

Is Diagnocat FDA cleared in the US?

Yes, recently: K251072 (Segmentron Viewer, September 2025) and K252934 (Diagnocat, January 2026), both verifiable in openFDA under its US entity DGNCT, LLC. Note that the diagnostic-report feature set marketed internationally is broader than the US-cleared claims — the company itself says feature availability varies by country.

How much does Diagnocat cost?

US pricing is quote-only. Figures of €129/month (2D) and €249/month (3D, includes 5 CBCT reports and DICOM-to-STL) circulate for the international product but weren't confirmable on official pages as of July 2026. Subscriptions cap CBCT report counts per tier, and unused reports don't roll over.

What makes Diagnocat different from Pearl or Overjet?

CBCT. Diagnocat analyzes 3D volumes — 65+ conditions per tooth — and auto-segments CBCT into exportable STL models for surgical guides. The big-name US competitors are primarily 2D radiograph tools with 3D as a newer add-on.

Does Diagnocat integrate with my PMS?

It's largely hardware-agnostic on the imaging side (accepts DICOM and standard image formats from any device, named CBCT support for Dentsply Sirona, Vatech, Planmeca, Carestream). Named PMS integrations were not published on the pages we could verify.